<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02961335</url>
  </required_header>
  <id_info>
    <org_study_id>2014/208/HP</org_study_id>
    <nct_id>NCT02961335</nct_id>
  </id_info>
  <brief_title>Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases</brief_title>
  <acronym>Microsemio-PI</acronym>
  <official_title>Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases : A Multicentric Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diffuse parenchymal lung diseases (DPLD) include a variety of respiratory conditions that&#xD;
      affect either the pulmonary interstitium or the alveolar space . The etiological diagnosis of&#xD;
      DPLD is often challenging, because of the large number of pathological entities involved,&#xD;
      which share close clinical and radiological presentations. High resolution Chest CT, a key&#xD;
      diagnostic procedure in DPLD, is subject to significant inter-observer analysis variations,&#xD;
      so that the diagnosis sometimes requires a surgical or transbronchial lung biopsy sampling.&#xD;
      This invasive procedure is not devoid of morbidity and may be impossible to perform in&#xD;
      fragile patients. Therefore, the definite diagnosis of DPLD is usually achieved following a&#xD;
      multi-disciplinary expert consensus, based on careful medical history, chest CT and&#xD;
      bronchoalveolar lavage examinations.&#xD;
&#xD;
      Alveolar probe-based confocal laser endomicroscopy (pCLE) is a mini invasive endoscopic&#xD;
      technique that allows distal lung microscopic imaging in vivo, during a flexible bronchoscopy&#xD;
      performed under topical anaesthesia. Since 2006, Alveolar pCLE has been used in a monocentric&#xD;
      clinical trial at the Rouen University Hospital in more than 200 patients and healthy&#xD;
      volunteers. This allowed the first pCLE in-vivo description of normal pulmonary acinus, and&#xD;
      confirmed the safety of the technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity of confocal imaging (solid pattern) for the diagnostic of the pulmonary nodule</measure>
    <time_frame>Day 1</time_frame>
    <description>Confocal imaging will be considered as &quot;positive&quot; when both&#xD;
a solid pattern is displayed&#xD;
a diagnostic biopsy is obtained at the site of confocal imaging</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Diffuse Parenchymal Lung Diseases</condition>
  <arm_group>
    <arm_group_label>Patient who need to undergo bronchoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient who need to undergo bronchoscopy. During bronchoscopy, biopsy sampling and Confocal microendoscopy will be done</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bronchoscopy</intervention_name>
    <description>Patient who need to undergo bronchoscopy. During bronchoscopy, biopsy sampling and Confocal microendoscopy will be done</description>
    <arm_group_label>Patient who need to undergo bronchoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Confocal microendoscopy</intervention_name>
    <description>Confocal microendoscopy will be performed during this initial bronchoscopy</description>
    <arm_group_label>Patient who need to undergo bronchoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy sampling</intervention_name>
    <description>Patient who need to undergo bronchoscopy. During bronchoscopy, biopsy sampling and Confocal microendoscopy will be done</description>
    <arm_group_label>Patient who need to undergo bronchoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age â‰¥ 18&#xD;
&#xD;
          -  signed written informed consent&#xD;
&#xD;
          -  indication for a flexible bronchoscopy&#xD;
&#xD;
          -  DPLD characterized by clinical and radiological data compatible with : idiopathic&#xD;
             pulmonary fibrosis (IPF), acute or chronic hypersensitivity pneumonitis (HPS),&#xD;
             sarcoidosis, or asbestosis.&#xD;
&#xD;
          -  Initial histological confirmation of the disease is not required for the inclusion of&#xD;
             the patient and the realisation of the alveolar bronchoscopy.&#xD;
&#xD;
          -  non-smoking or smoking cessation &gt;6 month&#xD;
&#xD;
          -  Patient affiliated with, or beneficiary of a social security category&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  respiratory failure and contraindication for a flexible bronchoscopy (this item will&#xD;
             stay at the appreciation of the physician, arterial blood gaz sampling being not&#xD;
             required)&#xD;
&#xD;
          -  bleeding disorder which would be not compatible with the realization of a flexible&#xD;
             bronchoscopy&#xD;
&#xD;
          -  history of pneumonectomy or non functional lung controlateral to the pCLE procedure&#xD;
&#xD;
          -  patients for which a per-endoscopic distal lung cryobiopsy is forecasted during the&#xD;
             first diagnostic bronchoscopy,&#xD;
&#xD;
          -  patients for which the bronchoscopy needs a general anesthesia and mechanical&#xD;
             ventilation during the procedure&#xD;
&#xD;
          -  anticoagulant or platelet aggregation inhibitors that cannot be interrupted for the&#xD;
             flexible bronchoscopy&#xD;
&#xD;
          -  patients for which a follow up or an adequate work-up to achieve the final diagnosis&#xD;
             will not be possible.&#xD;
&#xD;
          -  patients for which a cryobiopsy is forecasted during the bronchoscopy&#xD;
&#xD;
          -  pregnant and breast feeding women, or women of childbearing potential not taking&#xD;
             adequate contraception&#xD;
&#xD;
          -  Patients unable to understand informed consent&#xD;
&#xD;
          -  Patient on major legal measure of protection&#xD;
&#xD;
          -  Patients participating in an other interventional clinical trial at the inclusion date&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luc THIBERVILLE, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luc THIBERVILLE, Pr</last_name>
    <email>luc.thiverville@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Luc THIBERVILLE, Pr</last_name>
      <email>luc.thiberville@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Luc THIBERVILLE, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>November 8, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2016</study_first_posted>
  <last_update_submitted>May 25, 2018</last_update_submitted>
  <last_update_submitted_qc>May 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Interstitial</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

